VANCOUVER, Wash. Jie Xu, assistant professor in the School of Engineering and Computer Science at Washington State University Vancouver, has received $10,000 from TeloVISION LLC to support cancer-related research in the field of micro/nanofluidics.
TeloVISION () is a life-science company based in West Lafayette, Ind. that aims to provide physicians and cancer researchers with point-of-care solutions and technologies for rapid and inexpensive cancer diagnosis and therapeutic monitoring.
Xu is a well-recognized researcher in the field of micro/nanofluidics for biomedical applications. TeloVISION is sponsoring Xus research into microfluidic device for cell separation in hopes of one day providing the gold standard of cancer diagnosis and prognosis.
I plan to use the $10,000 to develop a microfluidic device using nanotechnologies. We hope this tiny device with specially engineered structures and properties will be able to separate cancer cells from blood cells. If successful, this technology may be used in point-of-care and clinical settings for cancer detection. TeloVISION is very interested in this research, said Xu.
Xu has authored more than 60 important journal and conference publications. He was the 2011 Defense Advanced Research Projects Agency Young Faculty Investigator, 2011 National New Faces of Engineering and 2009 Chinese Government awardee.
###
MEDIA CONTACTS
Rhona Sen Hoss, Development and Alumni Relations, 360-546-9281, rhona.senhoss@vancouver.wsu.edu
Brenda Alling, Office of Marketing and Communications, 360-546-9601, brenda_alling@vancouver.wsu.edu